World

Top 413 largest Companies in the Drug Manufacturers—Specialty & Generic industry in the World by Market Cap

This is the list of the largest public listed companies in the Drug Manufacturers—Specialty & Generic industry in the world by market capitalization with links to their reference stock.

World Drug Manufacturers—Specialty & Generic Industry Analysis
World Top Companies World Companies Analysis

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Top Drug Manufacturers—Specialty & Generic Companies in the World as of Jul. 01, 2024

Rank Company Market Cap (USD) Country Sector Industry
271 Maywufa Company Ltd $101.9 M Taiwan Taiwanese Healthcare Taiwanese Drug Manufacturers—Specialty & Generic
272 Fusen Pharmaceutical Company Ltd $101.3 M China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
273 Johnson Chemical Pharmaceutical Works Co. Ltd $97.8 M Taiwan Taiwanese Healthcare Taiwanese Drug Manufacturers—Specialty & Generic
274 Jilin Province Huinan Changlong Bio-pharmacy Company Ltd $97.5 M China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
275 Recro Pharma, Inc. $97.4 M

(June 1, 2022)

 United States US Healthcare US Drug Manufacturers—Specialty & Generic
276 Shineco, Inc. $97.2 M

(June 1, 2022)

 China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
277 Relmada Therapeutics, Inc. $91.7 M United States US Healthcare US Drug Manufacturers—Specialty & Generic
278 Vistin Pharma ASA $91.5 M Norway Norway Healthcare Norway Drug Manufacturers—Specialty & Generic
279 Laboratorios Richmond S.A.C.I.F. $87.8 M Argentina Argentinian Healthcare Argentinian Drug Manufacturers—Specialty & Generic
280 Harborside, Inc. $86.2 M

(Sept. 1, 2022)

 United States US Healthcare US Drug Manufacturers—Specialty & Generic
281 Biosyent, Inc. $85.2 M Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
282 HLS Therapeutics Inc. $84.3 M Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
283 Dali Pharmaceutical Co. Ltd $83.0 M China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
284 GeneFerm Biotechnology Co. Ltd $82.9 M Taiwan Taiwanese Healthcare Taiwanese Drug Manufacturers—Specialty & Generic
285 Vita Life Sciences Limited $81.9 M Australia Australian Healthcare Australian Drug Manufacturers—Specialty & Generic
286 Oasmia Pharmaceutical AB $76.7 M

(June 1, 2022)

 Sweden Swedish Healthcare Swedish Drug Manufacturers—Specialty & Generic
287 4Front Ventures Corp $73.9 M United States US Healthcare US Drug Manufacturers—Specialty & Generic
288 Anxo Pharmaceutical Co. Ltd $73.3 M Taiwan Taiwanese Healthcare Taiwanese Drug Manufacturers—Specialty & Generic
289 TSH Biopharm Corp Ltd $72.5 M Taiwan Taiwanese Healthcare Taiwanese Drug Manufacturers—Specialty & Generic
290 Green Organic Dutchman Holdings Ltd. $71.7 M

(Sept. 1, 2021)

 Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
291 Eagle Pharmaceuticals, Inc. $71.3 M United States US Healthcare US Drug Manufacturers—Specialty & Generic
292 SCYNEXIS, Inc. $70.7 M United States US Healthcare US Drug Manufacturers—Specialty & Generic
293 Venture Life Group plc $70.5 M United Kingdom UK Healthcare UK Drug Manufacturers—Specialty & Generic
294 Endo International plc $68.8 M

(Oct. 1, 2022)

 Ireland Irish Healthcare Irish Drug Manufacturers—Specialty & Generic
295 MariMed, Inc. $68.3 M United States US Healthcare US Drug Manufacturers—Specialty & Generic
296 FUREN Group Pharmaceutical Co. Ltd $66.6 M

(June 1, 2023)

 China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
297 Sakar Healthcare Ltd $66.3 M India Indian Healthcare Indian Drug Manufacturers—Specialty & Generic
298 Orexo AB $66.0 M Sweden Swedish Healthcare Swedish Drug Manufacturers—Specialty & Generic
299 ProPhase Labs, Inc. $65.8 M United States US Healthcare US Drug Manufacturers—Specialty & Generic
300 Theratechnologies Inc. $62.6 M Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic

Top Drug Manufacturers—Specialty & Generic Companies in the World as of Jul. 01, 2024

271. Maywufa Company Ltd

Company Profile: Maywufa Company Ltd
Market Cap (USD): $101.9 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Drug Manufacturers—Specialty & Generic

272. Fusen Pharmaceutical Company Ltd

Company Profile: Fusen Pharmaceutical Company Ltd
Market Cap (USD): $101.3 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

273. Johnson Chemical Pharmaceutical Works Co. Ltd

Company Profile: Johnson Chemical Pharmaceutical Works Co. Ltd
Market Cap (USD): $97.8 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Drug Manufacturers—Specialty & Generic

274. Jilin Province Huinan Changlong Bio-pharmacy Company Ltd

Company Profile: Jilin Province Huinan Changlong Bio-pharmacy Company Ltd
Market Cap (USD): $97.5 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

275. Recro Pharma, Inc.

Company Profile: Recro Pharma, Inc.
Market Cap (USD): $97.4 M (June 1, 2022)
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

276. Shineco, Inc.

Company Profile: Shineco, Inc.
Market Cap (USD): $97.2 M (June 1, 2022)
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

277. Relmada Therapeutics, Inc.

Company Profile: Relmada Therapeutics, Inc.
Market Cap (USD): $91.7 M
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

278. Vistin Pharma ASA

Company Profile: Vistin Pharma ASA
Market Cap (USD): $91.5 M
Country: Norway
Sector: Norway Healthcare
Industry: Norway Drug Manufacturers—Specialty & Generic

279. Laboratorios Richmond S.A.C.I.F.

Company Profile: Laboratorios Richmond S.A.C.I.F.
Market Cap (USD): $87.8 M
Country: Argentina
Sector: Argentinian Healthcare
Industry: Argentinian Drug Manufacturers—Specialty & Generic

280. Harborside, Inc.

Company Profile: Harborside, Inc.
Market Cap (USD): $86.2 M (Sept. 1, 2022)
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

281. Biosyent, Inc.

Company Profile: Biosyent, Inc.
Market Cap (USD): $85.2 M
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

282. HLS Therapeutics Inc.

Company Profile: HLS Therapeutics Inc.
Market Cap (USD): $84.3 M
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

283. Dali Pharmaceutical Co. Ltd

Company Profile: Dali Pharmaceutical Co. Ltd
Market Cap (USD): $83.0 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

284. GeneFerm Biotechnology Co. Ltd

Company Profile: GeneFerm Biotechnology Co. Ltd
Market Cap (USD): $82.9 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Drug Manufacturers—Specialty & Generic

285. Vita Life Sciences Limited

Company Profile: Vita Life Sciences Limited
Market Cap (USD): $81.9 M
Country: Australia
Sector: Australian Healthcare
Industry: Australian Drug Manufacturers—Specialty & Generic

286. Oasmia Pharmaceutical AB

Company Profile: Oasmia Pharmaceutical AB
Market Cap (USD): $76.7 M (June 1, 2022)
Country: Sweden
Sector: Swedish Healthcare
Industry: Swedish Drug Manufacturers—Specialty & Generic

287. 4Front Ventures Corp

Company Profile: 4Front Ventures Corp
Market Cap (USD): $73.9 M
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

288. Anxo Pharmaceutical Co. Ltd

Company Profile: Anxo Pharmaceutical Co. Ltd
Market Cap (USD): $73.3 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Drug Manufacturers—Specialty & Generic

289. TSH Biopharm Corp Ltd

Company Profile: TSH Biopharm Corp Ltd
Market Cap (USD): $72.5 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Drug Manufacturers—Specialty & Generic

290. Green Organic Dutchman Holdings Ltd.

Company Profile: Green Organic Dutchman Holdings Ltd.
Market Cap (USD): $71.7 M (Sept. 1, 2021)
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

291. Eagle Pharmaceuticals, Inc.

Company Profile: Eagle Pharmaceuticals, Inc.
Market Cap (USD): $71.3 M
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

292. SCYNEXIS, Inc.

Company Profile: SCYNEXIS, Inc.
Market Cap (USD): $70.7 M
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

293. Venture Life Group plc

Company Profile: Venture Life Group plc
Market Cap (USD): $70.5 M
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Drug Manufacturers—Specialty & Generic

294. Endo International plc

Company Profile: Endo International plc
Market Cap (USD): $68.8 M (Oct. 1, 2022)
Country: Ireland
Sector: Irish Healthcare
Industry: Irish Drug Manufacturers—Specialty & Generic

295. MariMed, Inc.

Company Profile: MariMed, Inc.
Market Cap (USD): $68.3 M
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

296. FUREN Group Pharmaceutical Co. Ltd

Company Profile: FUREN Group Pharmaceutical Co. Ltd
Market Cap (USD): $66.6 M (June 1, 2023)
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

297. Sakar Healthcare Ltd

Company Profile: Sakar Healthcare Ltd
Market Cap (USD): $66.3 M
Country: India
Sector: Indian Healthcare
Industry: Indian Drug Manufacturers—Specialty & Generic

298. Orexo AB

Company Profile: Orexo AB
Market Cap (USD): $66.0 M
Country: Sweden
Sector: Swedish Healthcare
Industry: Swedish Drug Manufacturers—Specialty & Generic

299. ProPhase Labs, Inc.

Company Profile: ProPhase Labs, Inc.
Market Cap (USD): $65.8 M
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

300. Theratechnologies Inc.

Company Profile: Theratechnologies Inc.
Market Cap (USD): $62.6 M
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

Top 1-year algo backtest: +265.99% - Try Disfold DeepFinance for FREE now!

Stay in touch